Show simple item record

FieldValueLanguage
dc.contributor.authorMurray, Elizabeth Jane
dc.date.accessioned2014-02-20
dc.date.available2014-02-20
dc.date.issued2014-02-20
dc.identifier.urihttp://hdl.handle.net/2123/10072
dc.description.abstractThis thesis addresses treatment outcomes for idiopathic childhood apraxia of speech (CAS), a significant and persistent disorder of speech motor planning and programming. There is a need for greater external evidence to guide clinical decision making. A systematic review of CAS treatment research published from 1970 to 2012 found there are no published randomised control trials (RCTs) for CAS. Three treatments showed strong preliminary evidence to warrant inclusion in future RCTs: Dynamic Temporal and Tactile Cueing, Rapid Syllable Transition Treatment (ReST) and Integrated Phonological Awareness intervention. A constraint on treatment outcomes is the lack of a validated, clinically replicable procedure for differentiating CAS from all other speech sound disorders (SSDs). A methodological protocol was developed for differential diagnosis of idiopathic CAS and a parallel group RCT. The diagnostic study examined 47 children referred with suspected CAS. CAS was determined from other SSDs using the current gold standard, expert judgment using the ASHA (2007) and the Shriberg, Potter and Strand (2009) feature lists. 100% diagnostic reliability was achieved. Assessment measures were analysed using discriminant function analysis and four measures in combination predicted the original diagnosis with 91% accuracy. Replication is required. The RCT compared the ReST and NDP3 treatments for 26 children aged 4-12 years in an intensive block (1 hour sessions, 4 days a week for 3 weeks) delivered by supervised speech pathology clinicians. The NDP3 showed significantly greater treatment gains within 1 week post treatment and the ReST treatment demonstrated greater maintenance and generalisation to pseudo-words. Overall ReST and NDP3 have strong evidence for treatment efficacy for CAS. The discussion argues that children with CAS can demonstrate strong treatment and generalisation effects when treatment considers best evidence, appropriate diagnosis and plans for generalisation.en_AU
dc.rightsThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en_AU
dc.subjectmotor speechen_AU
dc.subjectarticulationen_AU
dc.subjectprosodyen_AU
dc.subjectinterventionen_AU
dc.subjectmanagementen_AU
dc.subjectassessmenten_AU
dc.titleTreatment Efficacy for Children with Childhood Apraxia of Speechen_AU
dc.typeThesisen_AU
dc.date.valid2014-01-01en_AU
dc.type.thesisDoctor of Philosophyen_AU
usyd.facultyFaculty of Health Sciencesen_AU
usyd.departmentDiscipline of Speech Pathologyen_AU
usyd.degreeDoctor of Philosophy Ph.D.en_AU
usyd.awardinginstThe University of Sydneyen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.